Serum hepatocyte growth factor concentration in obese women decreases after vertical banded gastroplasty

Obesity Surgery

Volumn 15, Issue 6, 2005, Pages 803-808

  Swierczynski, Julian ^a   Korczynska, Justyna ^a   Goyke, Elzbieta ^a   Adrych, Krystian ^a   Raczynska, Sylwia ^a   Sledzinski, Zbigniew ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

BMI; Body fat mass; Hepatocyte growth factor; Morbid obesity; Vertical banded gastroplasty

Indexed keywords

CHOLESTEROL; INSULIN; LEPTIN; SCATTER FACTOR; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE; BODY FAT; BODY MASS; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE COURSE; FEMALE; GASTRIC BANDING; GASTROPLASTY; HUMAN; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; OBESITY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; VERTICAL BANDED GASTROPLASTY;

ADIPOSE TISSUE; ADULT; AGED; FEMALE; GASTROPLASTY; HEPATOCYTE GROWTH FACTOR; HUMANS; MIDDLE AGED; OBESITY, MORBID; POSTOPERATIVE PERIOD;

EID: 21344468811     PISSN: 09608923     EISSN: None     Source Type: Journal    
DOI: 10.1381/0960892054222678     Document Type: Article

References (28)

1. Gohda E, Tsubouchi H, Nakayama H et al. Purification and partial characterization of hepatocyte growth factor from plasma of patients with hepatic failure. J Clin Invest 1988; 81: 414-9.
2. Miyazawa K, Tsubouchi H, Naka D et al. Molecular cloning and sequence analysis of cDNA for human hepatocyte growth factor. Biochem Biophys Res Commun 1989; 163: 967-73.
3. Nakamura T. Structure and function of hepatocyte growth factor. Prog Growth Factor Res 1991; 3: 67-86.
4. Nakamura T, Nawa K, Ichihara A. Partial purification and characterization of hepatocyte growth factor from serum hepatectomized rats. Biochem Biophys Res Commun 1984; 122: 1450-9.
5. Zarnegar R, Michalopoulas J. Purification and biological characterization of human hepatopoietin A, a polypetide growth factor for hepatocyte. Cancer Res 1989; 49: 3313-20.
6. Shimomura T, Kondo J, Ochiai M et al. Activation of the zymogen of hepatocyte growth factor activator by thrombin. J Biol Chem 1993; 268: 22927-32.
7. Shimomura T, Miyazawa K, Komiyama Y et al. Activation of heptocyte growth factor by two homologous proteases, blood-coagulation factor XIIa and hepatocyte growth factor activator. Eur J Biochem 1995; 229: 257-61.
8. Ishiki Y, Ohnishi H, Muto Y et al. Direct evidence that hepatocyte growth factor is a hepatotrophic factor for liver regeneration and has a potent antihepatitis effect in vivo. Hepatology 1991; 16: 1227-35.
9. Igawa T, Matsumoto K, Kanda S et al. Hepatocyte growth factor may function as renotropic factor for regenerations in rats with acute renal injury. Am J Physiol 1993; 65: F61-F69.
10. Nakamura Y, Morishita R, Higaki J et al. Expression of a local hepatocyte growth factor system in vascular tissues. Biochem Biophys Res Commun 1995; 215: 483-8.
11. Bottaro DP, Rubin JS, Faletto DL et al. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 1991; 251: 802-4.
12. Bussolino F, Di Renzo MF, Ziehe M et al. Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J Cell Biol 1992; 119: 629-41.
13. Ma H, Calderon TM, Fallon JT et al. Hepatocyte growth factor is a survival factor for endothelial cells and is expressed in human atherosclerotic plaques. Atherosclerosis 2002; 164: 79-87.
14. Shiota G, Umeki K, Okano J et al. Hepatocyte growth factor and acute phase proteins in patients with chronic liver diseases. J Med 1995; 26: 295-308.
15. Seidel C, Borset M, Turesson I et al. The Nordic Myeloma Study Group. Elevated serum concentrations of hepatocyte growth factor in patients with multiple myeloma. Blood 1999; 91: 806-12.
16. Rampino T, Libetta C, De Simone W et al. Hemodialysis stimulates hepatocyte growth factor release. Kidney Int 1998; 53: 1382-8.
17. Nishimura M, Nakano K, Ushiyama M et al. Increased serum concentrations of human hepatocyte growth factor in proliferative diabetic retinopathy. J Clin Endocrinol Metab 1998; 83: 195-8.
18. Tateishi J, Waku S, Masutani M et al. Hepatocyte growth factor as a potential predictor of the presence of artherosclerotic aorto-iliac artery disease. Am Heart J 2002; 143: 272-6.
19. Yoshiotomi Y, Kojima S, Umemoto T et al. Serum hepatocyte growth factor in patients with peripheral arterial occlusive disease. J Clin Endocrinol Metab 1999; 84: 2425-8.
20. Rehman J, Considine RV, Bovenkerk JE et al. Obesity is associated with increased levels of circulating hepatocytes growth factor. J Am Coll Cardiol 2003; 41: 1408-13.
21. Rahimi N, Saulnier R, Nakamura T et al. Role of hepatocyte growth factor in breast cancer: a novel mitogenic factor secreted by adipocytes. DNA Cell Biol 1994; 13: 1189-97.
22. Pasnik K, Krupa J, Stanowski E. Vertical banded gastroplasty: 6 years experience at a center in Poland. Obes Surg 2005; 15: 223-7.
23. Zabrocka L, Raczynska S, Goyke E et al. BMI is the main determinant of die circulating leptin in women after vertical banded gastroplasty. Obes Res 2004; 12: 505-12.
24. Geloneze B, Tambascia MA, Pareja JC et al. Serum leptin levels after bariatric surgery across a range of glucose tolerance from normal to diabetes. Obes Surg 2001; 11: 693-8.
25. Guldstrand M, Backman L, Adamson U et al. Lowering of circulating insulin and leptin is closely associated following weight reduction after vertical banded gastroplasty in obese women. Diabetes, Obesity and Metabolism 1999; 1: 53-5.
26. Matthews DR, Hosker JP, Rudenski AS et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia 1985; 28: 412-9.
27. Nakamura Y, Morishita R, Nakamura S et al. A vascular modulator, hepatocyte growth factor, is associated with systolic pressure. Hypertension 1996; 28: 409-34.
28. Yasuda S, Goto Y, Baba T et al. Enhanced secretion of cardiac hepatocyte growth factor from an infarct region is associated with less severe ventricular enlargement and improved cardiac function. J Am Coll Cardiol 2000; 36: 115-21.